Pradaxa Approved for Atrial Fibrillation

Links shared publicly online about this topic.

  • 787
    total visits

Pradaxa Approved for Atrial Fibrillation

health.yahoo.net

WEDNESDAY, Oct. 20 (HealthDay News) -- Pradaxa (dabigatran etexilate) has been approved by the U.S. Food and Drug Administration to help prevent stroke in people with a type of abnormal heart rhythm called atrial fibrillation.

View full resource at health.yahoo.net

Tags: Heart Disease, Arrhythmia, Atrial Fibrillation, Drug, FDA, News

  • Share

Most Recently Shared on October 21, 2010 at 1:40 am By:

HealthSociety Healthy Society

Pradaxa Approved for Atrial Fibrillation http://bit.ly/bAsyTa

1 year ago...

Afib, Stroke, and the New Anticoagulants, a Roundtable (with video) - QualityPoint Technologies

qualitypointtech.net — “(MedPage Today) -- The arrival of dabigatran, rivaroxaban, and the soon-to-be approved apixaban has changed the landscape of stroke prevention in atrial fibrillation. This exclusive roundtable discussion maps out the twists and turns.View full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on March 22, 2012 at 10:00 pm By:

MedicalFeed MedicalFeed Health News Feed

Afib, Stroke, and the New Anticoagulants, a Roundtable (with video): (MedPage Today) -- The arrival of dabigatran,... http://t.co/YGykIAZb

4 weeks ago...

Drug recommended by NICE for stroke prevention | News | Nursing Times

nursingtimes.net — “The National Institute for Health and Clinical Excellence (NICE) has recommended the oral anticoagulant dabigatran (Pradaxa) as an option for the prevention of stroke and systemic embolism in patients with atrial fibrillation.View full resource at nursingtimes.net

  • View Related
  • Share

Most Recently Shared on March 18, 2012 at 12:22 am By:

NursingTimes Nursing Times Health Magazine

News: Drug recommended by NICE for stroke prevention http://t.co/bXQbBII0

4 weeks ago...

Health Canada approves Boston Scientific's Blazer Open-Irrigated RFA Catheter

news-medical.net — “Boston Scientific Corporation today announced Health Canada approval of the Blazer Open-Irrigated Catheter, the Company's latest radiofrequency ablation (RFA) catheter designed to treat a variety of arrhythmias such as atrial fibrillation, atrial flutter, ventricular tachycardia and other supraventricular tachycardias.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on March 15, 2012 at 2:05 pm By:

NewsMedical News-Medical.Net Health News

Health Canada approves Boston Scientific's Blazer Open-Irrigated RFA Catheter: Boston Scientific Corporation tod... http://t.co/ZtVd5Sce

1 month ago...

Atrial fibrillation - dabigatran etexilate

guidance.nice.org.uk — “Atrial fibrillation - dabigatran etexilateView full resource at guidance.nice.org.uk

  • View Related
  • Share

Most Recently Shared on March 15, 2012 at 9:40 am By:

mimsonline MIMS Online Medical Publisher

NICE recommends dabigatran etexilate (Pradaxa) to prevent stroke and systemic embolism in patients with AF: http://t.co/sc2qhIMx

1 month ago...

New Blood Thinner Linked to Higher Heart Attack Risk - Heart Health Center - Everyday Health

everydayhealth.com — “But benefits of Pradaxa still outweigh risks for those with atrial fibrillation, experts say.View full resource at everydayhealth.com

  • View Related
  • Share

Most Recently Shared on January 10, 2012 at 6:25 pm By:

EverydayHealth Everyday Health Health Site

New blood thinner linked to higher heart attack risk: http://t.co/tpl2BP7z

3 months ago...

A VERY HAPPY NEW YEAR TO OUR SHU FOLLOWERS! PART 1 OF “WHAT HAPPENED TO YOUR HEART IN 2011?” Advice Information Review SmarterHeartUniversity.com Radio

smarterheartuniversity.com — “A VERY HAPPY NEW YEAR TO OUR SHU FOLLOWERS! PART 1 OF “WHAT HAPPENED TO YOUR HEART IN 2011?” Advice Information Review SmarterHeartUniversity.com RadioView full resource at smarterheartuniversity.com

  • View Related
  • Share

Most Recently Shared on January 2, 2012 at 8:22 pm By:

Just About To Start On Pradaxa (Newest posts first) - The People's Medicine Community

prescriptiondrug-info.com — “Having been treated for atrial fibrillation for 10 years I am about to switch from my regime of monthly blood testing on Coumadin to Pradaxa As you can imagine I have some trepidation at such a radical switch in treatment Whereas I will no longer need the blood tests having them gave me some comfort (Newest posts first)View full resource at prescriptiondrug-info.com

  • View Related
  • Share

Most Recently Shared on December 16, 2011 at 12:05 am By:

druginfo Medicine Community Support

" Having been treated for atrial fibrillation for 10 years I am about to switch from my regime of monthly blo http://t.co/1fBkf8h7

4 months ago...

EMA updates dabigatran label due to increased fatal bleeds

cardiovascularbusiness.com — “The European Medicines Agency (EMA) has updated the safety label for Boehringer Ingelheim’s dabigatran (Pradaxa) after several cases of fatal bleeding events were reported. The number of increased bleeds may stem from the increased use of the drug as a result of approval of a new indication (preventing stroke and systemic embolism in non-valvular atrial fibrillation patients), EMA said in a statement.View full resource at cardiovascularbusiness.com

  • View Related
  • Share

Most Recently Shared on November 21, 2011 at 5:32 pm By:

CardioBusiness CardioBusiness Health Magazine

EMA updates dabigatran label due to increased fatal bleeds - The European Medicines Agency (EMA) has updated the saf... http://t.co/LKyEslkQ

5 months ago...

ACP: HospitalistWeekly - 16 November 2011

acphospitalist.org — “ACP: HospitalistWeekly - 16 November 2011View full resource at acphospitalist.org

  • View Related
  • Share

Most Recently Shared on November 16, 2011 at 12:00 pm By:

acphospitalist ACP Hospitalist Medical Journal

Tool stratifies risk of patients with acute #COPD exacerbations http://t.co/7dVxHdp6

5 months ago...

Letter to FDA Opposing Approval of Rivaroxaban (Xarelto) for Anticoagulation Therapy in Patients With Atrial Fibrillation

citizen.org — “Letter to FDA Opposing Approval of Rivaroxaban (Xarelto) for Anticoagulation Therapy in Patients With Atrial FibrillationView full resource at citizen.org

  • View Related
  • Share

Most Recently Shared on November 8, 2011 at 6:19 pm By:

SidneyWolfeMD Sidney Wolfe, MD Physician, Doctor, and Internist

@US_FDA ignores @Public_Citizen and expands Xarelto use to prevent strokes. See the letter we sent to the FDA. http://t.co/Qctgd29G

5 months ago...

FDA approves #warfarin alternative #rivaroxaban (#Xarelto) for atrial fibrillation #stroke prevention: http://t.co/GWrzoOcO #afib

stopafib.org — “FDA approves #warfarin alternative #rivaroxaban (#Xarelto) for atrial fibrillation #stroke prevention: http://t.co/GWrzoOcO #afibView full resource at stopafib.org

  • View Related
  • Share

Most Recently Shared on November 7, 2011 at 1:16 pm By:

Xarelto Approved for Atrial Fib Patients

webmd.com — “The FDA has approved Janssen's Xarelto to prevent stroke in patients with atrial fibrillation -- with a strong black box warning.View full resource at webmd.com

  • View Related
  • Share

Most Recently Shared on November 4, 2011 at 10:48 pm By:

WebMD_News WebMD_News Health News

Xarelto Approved for Atrial Fib Patients: The FDA has approved Janssen's Xarelto to prevent stroke in patients w... http://t.co/vs95V0gP

5 months ago...

FDA Okays Xarelto for Stroke Prevention - ABC News

abcnews.go.com — “The FDA has approved rivaroxaban (Xarelto) for prevention of stroke in patients with nonvalvular atrial fibrillation.View full resource at abcnews.go.com

  • View Related
  • Share

Most Recently Shared on November 4, 2011 at 8:11 pm By:

Xarelto (Rivaroxaban) Approved By FDA For Non-Valvular Atrial Fibrillation Patients

medicalnewstoday.com — “Xarelto (rivaroxaban), an anti-clotting medication, has been approved by the FDA for patients with non-valvular atrial fibrillation to reduce stroke risk. Xarelto, a Factor Xa inhibitor, acts at aView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on November 4, 2011 at 8:05 pm By:

mnt_heart MNT Heart News Health News

Xarelto (Rivaroxaban) Approved By FDA For Non-Valvular Atrial Fibrillation Patients http://t.co/I5BSybmw #heart #heartdisease

5 months ago...

Medical News: Public Citizen Calls on FDA to Nix Xarelto - in Cardiovascular, Arrhythmias from MedPage Today

medpagetoday.com — “The consumer group Public Citizen has asked the FDA not to approve rivaroxaban (Xarelto) for use in patients with atrial fibrillation because of safety and efficacy concerns.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on October 21, 2011 at 5:08 pm By:

Advertisement